ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,468 | -48.2% | 100,400 | -46.2% | 0.33% | -46.8% |
| Q4 2022 | $6,689 | -99.9% | 186,500 | -22.3% | 0.62% | -18.3% |
| Q3 2022 | $8,687,000 | +534.6% | 240,000 | +557.5% | 0.75% | +1408.0% |
| Q2 2022 | $1,369,000 | -78.9% | 36,500 | -77.5% | 0.05% | -94.8% |
| Q3 2021 | $6,476,000 | -81.1% | 161,900 | -79.2% | 0.97% | -81.0% |
| Q2 2021 | $34,236,000 | 0.0% | 778,800 | 0.0% | 5.08% | +6.1% |
| Q1 2021 | $34,236,000 | – | 778,800 | – | 4.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |